Research Article
Efficacy and Safety of Remimazolam Tosilate Combined with Propofol in Digestive Endoscopy: A Randomised Trial
Table 1
Comparison of the general conditions between the three groups.
| | Group RMP (n = 35) | Group RM (n = 40) | Group P (n = 38) | |
| Age (years) | 48.40 ± 11.16 | 48.40 ± 11.20 | 48.40 ± 12.56 | 0.848 | Height (cm) | 168.77 ± 7.41 | 168.77 ± 8.84 | 168.77 ± 8.43 | 0.295 | Weight (kg) | 65.64 ± 9.45 | 65.64 ± 8.48 | 65.64 ± 12.05 | 0.693 | BMI (kg/m2) | 22.98 ± 2.45 | 22.98 ± 2.38 | 22.98 ± 3.01 | 0.774 | Sex (M/F)a | 21/14 | 20/20 | 21/17 | 0.685 | ASA I/II | 20/15 | 24/16 | 26/12 | 0.582 | History of hypertension (N/Y)b | 26/9 | 32/8 | 30/8 | 0.822 | History of diabetes (N/Y) | 32/3 | 36/4 | 34/4 | 0.958 | History of smoking (N/Y) | 24/11 | 26/14 | 28/10 | 0.707 | History of drinking (N/Y) | 27/8 | 24/16 | 31/7 | 0.078 | History of dizziness (N/Y) | 35/0 | 39/1 | 38/0 | 0.351 | History of cephalagra (N/Y) | 34/1 | 37/3 | 36/2 | 0.657 | History of hypnagogue use (N/Y) | 33/2 | 40/0 | 35/3 | 0.099 | History of general anaesthesia (N/Y) | 20/15 | 25/15 | 26/12 | 0.608 |
|
|
aM/F: male/female. bN/Y: no/yes.
|